STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Revenue
2,612.76 2,620.00 2,782.17 3,030.90 3,107.52 4,223.40 4,536.27 5,138.70 5,459.50 5,935.90
Revenue Growth
16.71% 0.28% 6.19% 8.94% 2.53% 35.91% 7.41% 13.28% 6.24% 8.73%
Gross Profit
1,026.21 1,092.75 1,174.99 1,320.00 1,343.10 1,883.01 1,980.73 2,218.10 2,402.70 2,626.50
Operating Income
226.21 399.88 411.02 537.05 548.37 477.81 791.10 836.10 866.60 1,101.80
EBT
184.65 354.98 369.03 498.75 517.53 366.80 680.27 702.80 796.20 1,047.30
Income after Tax
110.63 291.62 304.75 407.86 396.87 284.46 556.20 553.30 611.50 785.10
Net Income Common
109.97 290.92 303.72 407.66 397.40 243.89 107.03 378.20 614.60 782.30
EPS (Diluted)
1.28 3.39 3.56 4.76 4.63 2.48 1.07 3.81 6.20 7.93
Shares (Diluted, Weighted)
86.09 85.71 85.47 85.64 85.90 98.33 100.25 99.40 99.10 98.70
Gross Margin
39.28% 41.71% 42.23% 43.55% 43.22% 44.59% 43.66% 43.16% 44.01% 44.25%
EBIT Margin
8.66% 15.26% 14.77% 17.72% 17.65% 11.31% 17.44% 16.27% 15.87% 18.56%
Net Profit Margin
4.21% 11.10% 10.92% 13.45% 12.79% 5.77% 2.36% 7.36% 11.26% 13.18%
Free Cash Flow Margin
9.80% 11.23% 12.77% 12.54% 14.51% 9.45% 9.03% 12.07% 14.42% 16.56%
EBITDA
472.70 578.22 636.94 734.28 767.61 1,097.58 1,351.36 1,406.10 1,342.80 1,588.30
EBIT
226.21 399.88 411.02 537.05 548.37 477.81 791.10 836.10 866.60 1,101.80

Show all line items

In millions of $ except per-share values · columns are period end dates